Introduction of SOPs for initially calculated antibiotic therapy in adults: A new computer program at the Charité;Einführung von SOPs zur initialen kalkulierten antibiotikatherapie bei erwachsenen: Ein neues computerprogramm an der charité

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 41, Issue 10, 2006, Pages 626-635

  Nachtigall, Irit ^b   Deja, Maria ^b   Halle, Elke ^a   Kastrup, Marc ^b   Weber Carstens, Steffen ^b   Krieg, Hanno ^b   Puhlmann, Birgit ^b   Eggers, Verena ^b   Heymann, Anja ^b   Rohr, Jürgen ^b   Viviano, Edoardo ^b   Von Dossow, Vera ^b   MacGuill, Martin ^b   Sander, Michael ^b   Göbel, Ulf ^b   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Campus Virchow Klinikum und Campus Charité Mitte ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE PLUS CEFTAZIDIME PLUS CLINDAMYCIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTAZIDIME PLUS CIPROFLOXACIN; CEFTAZIDIME PLUS CLINDAMYCIN PLUS CIPROFLOXACIN; CEFTRIAXONE; CEFTRIAXONE PLUS CLINDAMYCIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CIPROFLOXACIN PLUS MEROPENEM; CIPROFLOXACIN PLUS TAZOBACTAM; CLAVULANIC ACID; CLINDAMYCIN; CLINDAMYCIN PLUS LEVOFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MEROPENEM PLUS CIPROFLOXACIN; MOXIFLOXACIN; PIPERACILLIN; SULBACTAM; TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC THERAPY; COMPUTER PROGRAM; HUMAN; MEDICAL PRACTICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA; REVIEW;

ALGORITHMS; ANTI-INFECTIVE AGENTS; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG THERAPY, COMPUTER-ASSISTED; GERMANY; HOSPITALS, UNIVERSITY; QUALITY ASSURANCE, HEALTH CARE; SOFTWARE;

EID: 33750508977     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-955857     Document Type: Review

References (8)

1. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005;19:CD003543
2. Kollef MH. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J. Med. 2003;115:582-4
3. Gyssens IC. International guidelines for infectious diseases: a practical guide. Neth J Med 2005;63:291-9
4. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care 2005;50:714-21
5. Iregui M, Ward S, Sherman C, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002;122:262-8
6. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162):505-11
7. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator- associated pneumonia in adults: a randomized trial. JAMA 2003 19;290:2588-98
8. Bauer TT, Ewig S, Marre R, Suttorp N, Welte T; The CAPNETZ Study Group. J Intern Med. 2006 Jul;260(1):93-101. CRB-65 predicts death from community-acquired pneumonia.